L&T Technology Services Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹37,248 Cr
- Book Value
- ₹611
- Stock P/E
- 27.7
- Dividend Yield
- 1.66%
- ROE
- 21.5%
- ROCE
- 26.7%
- PEG Ratio
- 1.76
- EV/EBITDA
- 16.1
Fundamentals from Screener.in, as of 5 Aug 2026. Live price via Yahoo Finance.
L&T Technology Services share price today
L&T Technology Services (NSE: LTTS) is pure-play engineering R&D — not IT maintenance, but the outsourced design of the products themselves: vehicle software, medical devices, plant engineering, telecom silicon. Global companies now externalise engineering the way they externalised IT twenty years ago, and India hosts the talent arbitrage plus, increasingly, the innovation itself.
Within the listed ER&D trio, LTTS is the broad-spectrum player — mobility, tech, and process/plant engineering — and, at 27.7× with a 1.7% dividend yield, decisively the cheapest quality franchise in the space. Our universe tags it wait, with the note that this is where ER&D value hides.
Breadth as strategy
Where KPIT went all-in on automotive software and Tata Elxsi on design, LTTS kept three legs: mobility (auto/aero engineering), tech (semis, media, hyperscalers), and plant engineering (the L&T parentage advantage — process-industry digitalisation few rivals match). Breadth smooths sector cycles and lets large multi-vertical deals land. The 26.7% ROCE and steady mid-teens compounding do the rest.
Watch-items: auto-sector R&D budget cycles, the SWC (software-defined everything) deal pipeline, wage inflation on an 17.8% OPM, and parent-related governance (L&T’s 73.5% holding keeps float thin).
The numbers
From our research universe snapshot (5 Aug 2026):
| Metric | Value |
|---|---|
| Market cap | ₹37,248 Cr |
| P/E (TTM) | 27.7 |
| EV/EBITDA | 16.1 |
| Operating margin | 17.8% |
| ROE / ROCE | 21.5% / 26.7% |
| Debt to equity | 0.09 |
| Sales CAGR (5y) | 15.1% |
| Profit CAGR (5y) | 15.8% |
| Promoter holding | 73.5% |
| EPS (TTM) | ₹126.4 |
LTTS share price target 2026 to 2030
EPS base ₹126.4 (TTM). Bear: global R&D budgets freeze — 7% growth, multiple at 19×. Base: ER&D outsourcing compounds mid-teens — 13% growth at 25×. Bull: software-defined products accelerate every vertical — 17% growth at 32×.
| Year | Bear (19×, +7%) | Base (25×, +13%) | Bull (32×, +17%) |
|---|---|---|---|
| 2026 | ₹2,570 | ₹3,570 | ₹4,730 |
| 2027 | ₹2,750 | ₹4,035 | ₹5,535 |
| 2028 | ₹2,940 | ₹4,560 | ₹6,480 |
| 2029 | ₹3,150 | ₹5,150 | ₹7,580 |
| 2030 | ₹3,370 | ₹5,820 | ₹8,870 |
From ₹3,502, the base case is ≈ +66% over four and a half years plus the 1.7% yield — and the bear case is only −4%. When the downside rounds to zero and the base case compounds in the teens, patience is being paid properly. The range below sharpens it further.
Reasons to own LTTS (at the right price)
- The cheapest quality ER&D franchise — 27.7× against peers at 33–74×.
- Three-vertical breadth smooths what pure-plays suffer alone.
- Plant-engineering moat inherited from the L&T parent — rivals can’t fake process depth.
- ER&D outsourcing is a structural decade trade, not an IT-budget cycle.
- 26.7% ROCE, near-zero debt, and a real dividend while you compound.
The risks: auto R&D cycles bite the mobility segment, ER&D pricing is deal-lumpy, and the thin float exaggerates every disappointment.
Should you buy at the current price?
The live buy range below is for members — where ER&D value gets undeniable.
FAQ
What is the LTTS share price target for 2030? Base case ≈ ₹5,820 (25× on 13% compounded growth), bear ≈ ₹3,370, bull ≈ ₹8,870. Arithmetic above.
How is LTTS different from an IT services company? IT services maintain systems; ER&D designs products. LTTS engineers vehicle software, medical devices and plants — higher-value work, stickier client relationships, different budget line.
Why is LTTS cheaper than KPIT or Tata Elxsi? Slower headline growth and a diversified (less story-pure) mix. The scenarios above show what that discount buys: near-zero modelled downside with teens compounding.
When are LTTS’s next results? Track the exact date on our results calendar.
This article is research and education, not personalised investment advice. We are not SEBI-registered advisers. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.